BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33780805)

  • 1. Development of an inactivated combined vaccine for protection of cattle against lumpy skin disease and bluetongue viruses.
    Es-Sadeqy Y; Bamouh Z; Ennahli A; Safini N; El Mejdoub S; Omari Tadlaoui K; Gavrilov B; El Harrak M
    Vet Microbiol; 2021 May; 256():109046. PubMed ID: 33780805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus.
    Gari G; Abie G; Gizaw D; Wubete A; Kidane M; Asgedom H; Bayissa B; Ayelet G; Oura CA; Roger F; Tuppurainen ES
    Vaccine; 2015 Jun; 33(28):3256-61. PubMed ID: 26056063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Evaluation of an Inactivated Lumpy Skin Disease Vaccine for Cattle.
    Hamdi J; Boumart Z; Daouam S; El Arkam A; Bamouh Z; Jazouli M; Tadlaoui KO; Fihri OF; Gavrilov B; El Harrak M
    Vet Microbiol; 2020 Jun; 245():108689. PubMed ID: 32456824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on the incidence of adverse reactions, viraemia and haematological changes following field immunization of cattle using a live attenuated vaccine against lumpy skin disease.
    Katsoulos PD; Chaintoutis SC; Dovas CI; Polizopoulou ZS; Brellou GD; Agianniotaki EI; Tasioudi KE; Chondrokouki E; Papadopoulos O; Karatzias H; Boscos C
    Transbound Emerg Dis; 2018 Feb; 65(1):174-185. PubMed ID: 28391652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field study on the use of vaccination to control the occurrence of lumpy skin disease in Ethiopian cattle.
    Molla W; Frankena K; Gari G; de Jong MCM
    Prev Vet Med; 2017 Nov; 147():34-41. PubMed ID: 29254724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of Neethling lumpy skin disease virus and x10RM65 sheep-pox live attenuated vaccines for the prevention of lumpy skin disease - The results of a randomized controlled field study.
    Ben-Gera J; Klement E; Khinich E; Stram Y; Shpigel NY
    Vaccine; 2015 Sep; 33(38):4837-42. PubMed ID: 26238726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency vaccination of cattle against lumpy skin disease: Evaluation of safety, efficacy, and potency of MEVAC
    Bazid AH; Wasfy M; Fawzy M; Nayel M; Abdelmegeid M; Thabet RY; Yong HS; El-Sayed MM; Magouz A; Badr Y
    Vet Res Commun; 2023 Jun; 47(2):767-777. PubMed ID: 36460903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goatpox virus (G20-LKV) vaccine strain elicits a protective response in cattle against lumpy skin disease at challenge with lumpy skin disease virulent field strain in a comparative study.
    Zhugunissov K; Bulatov Y; Orynbayev M; Kutumbetov L; Abduraimov Y; Shayakhmetov Y; Taranov D; Amanova Z; Mambetaliyev M; Absatova Z; Azanbekova M; Khairullin B; Zakarya K; Tuppurainen E
    Vet Microbiol; 2020 Jun; 245():108695. PubMed ID: 32456811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats.
    Boshra H; Truong T; Nfon C; Bowden TR; Gerdts V; Tikoo S; Babiuk LA; Kara P; Mather A; Wallace DB; Babiuk S
    Antiviral Res; 2015 Nov; 123():39-49. PubMed ID: 26341190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Evaluation of a Combined Contagious Bovine Pleuropneumonia (CBPP) and Lumpy Skin Disease (LSD) Live Vaccine.
    Safini N; Elmejdoub S; Bamouh Z; Jazouli M; Hamdi J; Boumart Z; Rhazi H; Tadlaoui KO; El Harrak M
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215965
    [No Abstract]   [Full Text] [Related]  

  • 12. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
    Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
    Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
    Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.
    Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G
    Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus.
    Tuppurainen ES; Pearson CR; Bachanek-Bankowska K; Knowles NJ; Amareen S; Frost L; Henstock MR; Lamien CE; Diallo A; Mertens PP
    Antiviral Res; 2014 Sep; 109():1-6. PubMed ID: 24973760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Grimm L; Meilwes J; Punsmann T; Blaha I; Salditt A; Rohn K; Bastian M; Ganter M
    Vaccine; 2019 Sep; 37(39):5844-5853. PubMed ID: 31431410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bluetongue vaccines: the past, present and future.
    Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
    Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response to repeated lumpy skin disease virus vaccination and performance of serological tests.
    Milovanović M; Dietze K; Milićević V; Radojičić S; Valčić M; Moritz T; Hoffmann B
    BMC Vet Res; 2019 Mar; 15(1):80. PubMed ID: 30841894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumpy skin disease outbreaks in Greece during 2015-16, implementation of emergency immunization and genetic differentiation between field isolates and vaccine virus strains.
    Agianniotaki EI; Tasioudi KE; Chaintoutis SC; Iliadou P; Mangana-Vougiouka O; Kirtzalidou A; Alexandropoulos T; Sachpatzidis A; Plevraki E; Dovas CI; Chondrokouki E
    Vet Microbiol; 2017 Mar; 201():78-84. PubMed ID: 28284627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.